Use of magnetic navigation to facilitate transcatheter alcohol septal ablation for hypertrophic obstructive cardiomyopathy

Journal of Invasive Cardiology

Volumn 18, Issue 6, 2006, Pages

  Bach, Richard G ^a   Leach, Christopher ^a   Milov, Simon A ^a   Lindsay, Bruce D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiomyopathy; Catheter ablation; Coronary angiography; Coronary circulation; Ethanol; Heart catheterization; Heart septum; Hypertrophic

Indexed keywords

DISOPYRAMIDE; METOPROLOL; ALCOHOL DERIVATIVE; DIAGNOSTIC AGENT;

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; CASE REPORT; CATHETER ABLATION; CLINICAL FEATURE; ECHOCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MAGNETIC FIELD; MALE; MITRAL VALVE; RADIOFREQUENCY ABLATION; ANGIOCARDIOGRAPHY; CORONARY BLOOD VESSEL; HEART VENTRICLE SEPTUM; HYPERTROPHIC CARDIOMYOPATHY; INSTRUMENTATION; MAGNETISM; METHODOLOGY; MIDDLE AGED; RADIOGRAPHY; STEREOTAXIC SURGERY;

ALCOHOLS; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; CORONARY ANGIOGRAPHY; CORONARY VESSELS; HEART SEPTUM; HUMANS; MAGNETICS; MALE; MIDDLE AGED; STEREOTAXIC TECHNIQUES;

EID: 33747118391     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy Lancet 1995;346:211-214.
2. Knight C, Kurbaan AS, Seggewiss H. et al. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation 1997;95:2075-2081.
3. Lakkis NM, Nagueh SF, Kleiman NS, et al. Spencer WH 3rd. Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation 1998;98:1750-1755.
4. Seggewiss H, Gleichmann U, Faber L, et al. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol 1998;31:252-258.
5. Faber L, Seggewiss H, Gleichmann U. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Results with respect to intraprocedural myocardial contrast echocardiography. Circulation 1998:98:2415-2421.
6. Lakkis NM, Nagueh SF, Dunn JK, et al. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: One-year follow-up. J Am Coll Cardiol 2000;36:852-855.
7. Faber L, Welge D, Seggewiss H, et al. Echo-guided septal ablation for hypertrophic obstructive cardiomyopathy: Six years of experience (Abstr). J Am Coll Cardiol 2003;4 (suppl A):144A.
8. Faddis MN. Blume W. Finney JA, et al. Novel, magnetically guided catheter for endocardial mapping and radiofrequency catheter ablation. Circulation 2002;106:2980-2985.
9. Faddis MN. Chen J. Osborn J. Talcott M, et al. Magnetic guidance system for cardiac electrophysiology: A prospective trial of safety and efficacy in humans. J Am Coll Cardiol 2003;42:1952-1958.
10. Faddis MN. Lindsay BD. Magnetic catheter manipulation. Cor Artery Dis 2003;14:25-27.
11. Gaspar J. Martinez-Rios MA. Vonderwalde C. et al. Pericardium-covered stent for septal myocardial ablation in hypertrophic obstructive cardiomyopathy. Catheter Cardiovasc Interv 1999;47:73-79.
12. Fifer MA, Yoerger DM, Picard MH, et al. Images in cardiovascular medicine. Covered stent septal ablation for hypertrophic obstructive cardiomyopathy: Initial success but ultimate failure resulting from collateral formation. Circulation 2003;107:3248-3249.
13. Yoerger DM. Weyman AE. Hypertrophic obstructive cardiomyopathy: Mechanism of obstruction and response to therapy. Rev Cardiovasc Med 2003;4:199-215.